| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-08 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |